Insights

Immunogen-grade expansion Athens Bioscience recently launched an immunogen-grade protein line, signaling a new high-purity product tier and potential cross-sell opportunities to customers requiring validated protein quality for diagnostics, MS workflows, and regulatory filings.

Regulatory-grade reliability With ISO 9001:2015 certified processes and 100 percent in-house production, the company offers traceable single-facility sourcing and robust quality systems that can win trust with IVD developers and formulators seeking compliant protein supplies.

Diverse protein portfolio Over 170 native proteins purified from human and animal sources serve multiple needs — calibration, media formulation, and research with native post-translational modifications — presenting multiple entry points for expanding current customer use cases.

End-to-end supply certainty All lots originate from the same processes and site, enabling predictable performance and strict lot-to-lot consistency, a strong selling point for customers needing reliable manufacturing for regulatory audits and reproducible experiments.

Growth-ready scale Capable of mg-scale research orders to kg-scale commercial production, Athens Bioscience can partner across stages from early development to commercial launches, aligning with firms seeking scalable, quality-driven protein supply.

Similar companies to Athens Bioscience, Inc.

Athens Bioscience, Inc. Tech Stack

Athens Bioscience, Inc. uses 8 technology products and services including Hotjar, Microsoft Clarity, Amazon Web Services, and more. Explore Athens Bioscience, Inc.'s tech stack below.

Athens Bioscience, Inc.'s Email Address Formats

Athens Bioscience, Inc. uses at least 1 email format:
Athens Bioscience, Inc. Email FormatsExamplePercentage
First.Last@athensresearch.comJohn.Doe@athensresearch.com
100%

Frequently Asked Questions

What is Athens Bioscience, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s official website is athensbioscience.com and has social profiles on LinkedIn.

How much revenue does Athens Bioscience, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Athens Bioscience, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Athens Bioscience, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Athens Bioscience, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Athens Bioscience, Inc. has approximately 28 employees across 3 continents, including North America, Europe and Asia. Key team members include Chairman & Chief Executive Officer: B. N., Research Director: V. P. and China Representative For Sales And Marketing: S. Z. Explore Athens Bioscience, Inc.'s employee directory with LeadIQ.

What industry does Athens Bioscience, Inc. belong to?

Minus sign iconPlus sign icon
Athens Bioscience, Inc. operates in the Biotechnology Research industry.

What technology does Athens Bioscience, Inc. use?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s tech stack includes Hotjar, Microsoft Clarity, Amazon Web Services, Cookiebot, BigCommerce, Microsoft 365, HubSpot and Vercel.

What is Athens Bioscience, Inc.'s email format?

Minus sign iconPlus sign icon
Athens Bioscience, Inc.'s email format typically follows the pattern of First.Last@athensresearch.com. Find more Athens Bioscience, Inc. email formats with LeadIQ.

When was Athens Bioscience, Inc. founded?

Minus sign iconPlus sign icon
Athens Bioscience, Inc. was founded in 1986.
Athens Bioscience, Inc. logo

Athens Bioscience, Inc.

Biotechnology ResearchGeorgia, United States11-50 Employees

Athens Bioscience, Inc. is a biotechnology company based in Athens, Georgia, focused on producing native human and animal proteins for diagnostic developers, cell culture media companies, and life science researchers. Its offerings are designed to address variability in assays, media performance, and research reproducibility by providing proteins with authentic native properties and consistent quality, produced entirely in-house under ISO 9001:2015-certified processes. The company serves customers who need proteins that preserve native post-translational modifications and physiological activity, with traceable quality and a single-site manufacturing footprint to streamline regulatory qualification and audits.
Operating within the biotechnology research sector, Athens Bioscience emphasizes reliability and consistency across all sizes of production, from small research orders to commercial-scale lots, ensuring uniformity across batches and lots. The firm highlights a centralized approach to purity, formulation, and scale tailored to customer specifications, positioning itself as a manufacturing partner rather than a traditional supplier. In recent developments, the company announced the launch of an immunogen-grade protein line, underscoring an expansion of its product offerings anchored in verified purity and composition.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1986
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Athens Bioscience, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.